🇺🇸 Aardvark Therapeutics, Inc.AARD

Company Update Form 8-K 22-10-2026 16:17:09 EDT

Subject: 8-K Items 8.01, 9.01

Overview: The FDA has lifted the clinical hold on ARD-101 for Prader-Willi Syndrome, allowing Aardvark Therapeutics to resume clinical development.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest